SciELO - Scientific Electronic Library Online

vol.52 issue2Carbamazepine kinetics in cardiac patients before and during amiodaronePoliomyelitis in Sergipe (Northeastern Brazil) author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X


TILBERY, Charles P.; FELIPE, Eduardo; MOTA, Izabel Maria  and  SCHEINBERG, Morton A.. Elevated levels of soluble interleukin-2 receptors in multiple sclerosis: preliminary report on 26 patients. Arq. Neuro-Psiquiatr. [online]. 1994, vol.52, n.2, pp.216-220. ISSN 0004-282X.

Serum samples were analysed for interleukin-2 receptors levels (sIL-2R) in 26 patients with definite multiple sclerosis as defined by Poser and col. Three groups of patients form the basis of this study: group I, with 14 patients with clinical evidence of active disease; group II, with 12 patients with clinically stable multiple sclerosis; and group III, with 8 patients with other neurological diseases. Blood was collected by venipuncture and centrifuged. All samples were stored at -20°C until testing. The assay used monoclonal antibodies against epitopes of interleukin-2 receptors. In the wells of a microtiter plate coated with anti-soluble interleukin-2 receptors (Immunotech SA) samples to be measured or standards are incubated in the presence of a second monoclonal antibody conjugated with alkaline phosphatase. The amount of bound enzyme-conjugate is measured by adding a chromogenic substrate. The intensity of the resulting colour is proportional to the sIL-2R concentration present in the sample. Increased serum levels of sIL-2R were found in 7 of 14 patients with active multiple sclerosis (50%), in only 1 of the 12 patients with clinically stable multiple sclerosis and in none of the patients with other neurological diseases.

Keywords : multiple sclerosis; active disease; soluble interleukin-2 receptors.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf epdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License